| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12 |
| filingDate |
1996-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21d17bb964600fb4e1610f0cf09f92c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c1d7e38a7d1d733a267d6fc3c8ecb83 |
| publicationDate |
1997-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0769297-A1 |
| titleOfInvention |
Use of nefazodone for the manufacture of a medicament for the treatment of panic attack |
| abstract |
Nefazodone and its pharmaceutically acceptable salts are useful in alleviation of panic disorders which can take the form of clinical syndromes comprising, for example, panic attacks, agoraphobia and phobic anxiety. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6384037-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6469008-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6586437-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6465470-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6465469-B1 |
| priorityDate |
1995-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |